TITLE

Moxifloxacin: A Viewpoint by Richard Wise

AUTHOR(S)
Wise, R.
PUB. DATE
March 1999
SOURCE
Drugs;Mar1999, Vol. 57 Issue 3, p374
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents views on the antimicrobial agent moxifloxacin. Respiratory pathogens and Gram-negative bacteria targeted by moxifloxacin; Comparison between moxifloxacin and ciprofloxacin; Mechanism of action.
ACCESSION #
9593134

 

Related Articles

  • Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital. Hae-Sun Chung; Seong Geun Hong; Yangsoon Lee; Myungsook Kim; Dongeun Yong; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong // Yonsei Medical Journal;Mar2012, Vol. 53 Issue 2, p439 

    We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and...

  • Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics. Troughton, Judith A.; Millar, Gary; Smyth, Edward T. M.; Doherty, Lorraine; McMullan, Ronan // Journal of Antimicrobial Chemotherapy (JAC);Sep2011, Vol. 66 Issue 9, p2152 

    Objectives A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem...

  • Fluoroquinolone resistance during 2000-2005 : An observational study. Ryan, Richard J.; Lindsell, Chris; Sheehan, Paul // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication. Unlike other fluoroquinolones used in our healthcare system, moxifloxacin's urinary excretion is low and thus we hypothesized that increased use of moxifloxacin is associated with an...

  • Patrones de resistencia bacteriana en urocultivos en un hospital oncológico. Cornejo-Juárez, Patricia; Velásquez-Acosta, Consuelo; Sandoval, Silvia; Gordillo, Patricia; Volkow-Fernández, Patricia // Salud Pública de México;sep/oct2007, Vol. 49 Issue 5, p330 

    Objective. To describe the patterns of antimicrobial resistance of organisms isolated from urine cultures at a teaching oncological hospital for adult patients. Material and Methods. All strains obtained from urine cultures from 1998 to 2005 were included. Mean susceptibilities were obtained for...

  • Strategies to Address Appropriate Fluoroquinolone Use in the Hospital. Kaye, Keith S.; Auwaerter, Paul; Bosso, John A.; Dean, Nathan C.; Doern, Gary V.; Kays, Michael B.; Pogue, Jason M.; Ritchie, David J.; Wispelwey, Brian // Hospital Pharmacy;Nov2010, Vol. 45 Issue 11, p844 

    Purpose: Strategies to optimally use fluoroquinolones in the hospital setting are reviewed.Summary: Fluoroquinolones possess broad-spectrum antimicrobial coverage and are widely used to treat a variety of infections including some serious, life-threatening conditions. Overuse and inappropriate...

  • Antibacterial Activity of Ethanol Extract of Andrographis paniculata. MISHRA, U. S.; MISHRA, A.; KUMARI, R.; MURTHY, P. N.; NAIK, B. S. // Indian Journal of Pharmaceutical Sciences;2009, Vol. 71 Issue 4, p436 

    In the present study the ethanol extract of the aerial part of Andrographis paniculata was prepared and evaluated for antimicrobial activity against eleven bacterial strains by determining minimum inhibitory concentration and zone of inhibition. Minimum inhibitory concentration values were...

  • Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates. JOSEPH, NOYAL MARIYA; BHANUPRIYA, B.; SHEWADE, DEEPAK GOPAL; HARISH, BELGODE NARASIMHA // Journal of Clinical & Diagnostic Research;Feb2015, Vol. 9 Issue 2, p8 

    Introduction: Gram negative organisms are one of the major causes of nosocomial diseases. Development of resistance to antibiotics by these organisms increases their risk in clinical treatment of patients. It also affects morbidity and mortality hence needs to be monitored and controlled. Aim:...

  • Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives. Xin Guo; Ming Liang Liu; Hui Yuan Guo; Yu Cheng Wang; Ju Xian Wang // Molecules;Mar2011, Vol. 16 Issue 3, p2626 

    A series of novel 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c]pyridin-5(4H)-yl)fluoroquinolone derivatives were designed, synthesized and characterized by 1H-NMR, MS and HRMS. These fluoroquinolones were evaluated for their in vitro antibacterial activity against representative...

  • Pro-rich Antimicrobial Peptides from Animals: Structure, Biological Functions and Mechanism of Action. Gennaro, Renato; Zanneti, Margherita; Benincasa, Monica; Poda, Elena; Miani, Monica // Current Pharmaceutical Design;Apr2002, Vol. 8 Issue 9, p763 

    Pro-rich antimicrobial peptides are a group of linear peptides of innate immunity isolated from mammals and invertebrates, and characterised by a high content of proline residues (up to 50%). Members of this group are predominantly active against Gram-negative bacterial species which they kill...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics